Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Regulatory News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 150.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 20.00 (14.286%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 150.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

2 Apr 2019 09:23

RNS Number : 8195U
Faron Pharmaceuticals Oy
02 April 2019
 

TR-1: Standard form for notification of major holdings

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Faron Pharmaceuticals Oy

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

X

An event changing the breakdown of voting rights

 

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

Name

Aviva plc & its subsidiaries

City and country of registered office (if applicable)

London, England

4. Full name of shareholder(s) (if different from 3.)v

Name

Registered Holder:

 

Chase (GA Group) Nominees Limited 963,938*

HSBC Global Custody Nominee (UK) Limited

284,539*

State Street Nominees Limited 8,365*

*denotes direct interest

BNY (Nominees) Limited 30,420

 

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reachedvi:

29/03/2019

6. Date on which issuer notified (DD/MM/YYYY):

01/04/2019

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

3.63%

 

3.63%

35,476,519

Position of previous notification (if

applicable)

4.86%

0.03%

4.89%

 

        

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary SharesFI4000153309

1,256,842

30,420

3.54%

0.09%

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

1,287,262

3.63%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

x

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Aviva plc

 

 

 

Aviva Group Holdings Limited

 

 

 

Aviva Investors Holdings Limited

 

 

 

Aviva Investors Global Services Limited

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

See Section 4

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional informationxvi

This notification is prompted by a 4% to 3% change at Combined Interest Level

 

 

     

 

Place of completion

Norwich, England

Date of completion

01 APRIL 2019

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLVLLBBKZFFBBV
Date   Source Headline
6th Nov 20183:52 pmRNSPDMR Dealings
23rd Oct 201811:05 amRNSSecond Price Monitoring Extn
23rd Oct 201811:00 amRNSPrice Monitoring Extension
23rd Oct 20189:06 amRNSSecond Price Monitoring Extn
23rd Oct 20189:00 amRNSPrice Monitoring Extension
22nd Oct 20183:00 pmRNSINTEREST trial update presented at ESICM
18th Sep 20189:23 amRNSDirector/PDMR Shareholding
17th Sep 20187:00 amRNSFaron announces CTA filing for Clevegen
13th Sep 20187:00 amRNSInterim Results
12th Sep 20187:00 amRNSNew data published on Clever-1 function
8th Aug 201811:05 amRNSSecond Price Monitoring Extn
8th Aug 201811:00 amRNSPrice Monitoring Extension
8th Aug 20187:00 amRNSNotice of Interim Results
9th Jul 20188:45 amRNSHolding(s) in Company
28th Jun 20187:00 amRNSClevegen successful toxicity studies
22nd Jun 20187:00 amRNSHoldings in Company
21st Jun 20183:58 pmRNSDirector/PDMR Shareholding
21st Jun 20189:00 amRNSPrice Monitoring Extension
21st Jun 20187:40 amRNSDirector/PDMR Shareholding
20th Jun 20182:05 pmRNSSecond Price Monitoring Extn
20th Jun 20182:00 pmRNSPrice Monitoring Extension
20th Jun 20188:43 amRNSHolding(s) in Company
18th Jun 20183:42 pmRNSHoldings in Company
15th Jun 20184:40 pmRNSSecond Price Monitoring Extn
15th Jun 20184:35 pmRNSPrice Monitoring Extension
14th Jun 201811:05 amRNSSecond Price Monitoring Extn
14th Jun 201811:00 amRNSPrice Monitoring Extension
14th Jun 20187:00 amRNSBiomarker analysis of Phase III INTEREST trial
31st May 20182:33 pmRNSResult of AGM
31st May 20187:00 amRNSAGM Statement
16th May 20185:53 pmRNSPDMR Shareholding
15th May 20183:14 pmRNSDirector/PDMR Shareholding
15th May 20182:05 pmRNSSecond Price Monitoring Extn
15th May 20182:00 pmRNSPrice Monitoring Extension
15th May 20181:16 pmRNSHoldings in Company
11th May 20184:51 pmRNSHolding(s) in Company
11th May 20181:37 pmRNSHolding(s) in Company
11th May 20181:34 pmRNSHolding(s) in Company
11th May 20187:00 amRNSUpdate on the Phase III INTEREST trial
10th May 201810:05 amRNSNotice of AGM
9th May 20184:40 pmRNSSecond Price Monitoring Extn
9th May 20184:35 pmRNSPrice Monitoring Extension
9th May 201812:54 pmRNSHoldings in Company
8th May 20189:05 amRNSSecond Price Monitoring Extn
8th May 20189:00 amRNSPrice Monitoring Extension
8th May 20187:00 amRNSTop line data from the Phase III INTEREST trial
8th May 20187:00 amRNSFinal Results for the year ended 31 December 2017
25th Apr 201812:43 pmRNSHoldings in Company
21st Mar 20187:00 amRNSNotice of Full Year Results
6th Mar 201812:54 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.